Explore
Trendline
Private Equity Firms Face Slowing Retail Investor Demand Amid Market Caution
Private Equity Firms Face Slowing Retail Investor Demand Amid Market Caution
Read More
Trendline
JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston
JCR Pharmaceuticals to Showcase Gene Therapy Innovations at ASGCT Meeting in Boston
Read More
Trendline
MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million
MacroGenics Sells Maryland Drug Manufacturing Plant to Bora for $122.5 Million
Read More
Trendline
MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million
MacroGenics Sells Maryland Drug Plant to Bora Pharmaceuticals for $122.5 Million
Read More
Trendline
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
MacroGenics to Sell Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million
Read More
Trendline
Retail Investor Demand for Evergreen Private Equity Slows Amid Valuation Concerns
Retail Investor Demand for Evergreen Private Equity Slows Amid Valuation Concerns
Read More
Trendline
Retail Investor Demand for Evergreen Private Equity Slows
Retail Investor Demand for Evergreen Private Equity Slows
Read More
Reuters
European equities fall as fragile Mideast ceasefire dents risk sentiment
By Twesha Dikshit May 12 (Reuters) - European shares fell on Tuesday as fading hopes of a U.S.-Iran peace deal pushed oil prices higher and kept investors on edge. U.S.
Read More
Trendline
Potential FDA Leadership Change Could Impact Biopharma Industry
Potential FDA Leadership Change Could Impact Biopharma Industry
Read More
Trendline
Avid Bioservices Names Kerri McCullough Wood as Chief Commercial Officer to Drive Growth
Avid Bioservices Names Kerri McCullough Wood as Chief Commercial Officer to Drive Growth
Read More
Trendline
Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges
Soligenix Reports First Quarter 2026 Financial Results Amid Clinical Trial Challenges
Read More
Trendline
Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments
Atossa Therapeutics Reports Q1 2026 Financial Results and Strategic Developments
Read More